The present study revealed that hyperbaric treatment at 1.3 ATA upregulates IL-10 in the skeletal muscle and improves insulin sensitivity and glucose tolerance in type 2 diabetes with obesity. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.